¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Journal of spinal disorders."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • spinal fusion
    ôÃßÀ¯ÇÕ(¼ú)
  • spinal ganglion
    ô¼ö½Å°æÀý
  • spinal headache
    ôÃ߸¶ÃëµÎÅë
  • spinal lemniscus
    ô¼ö¼¶À¯¶ì, ô¼ö¼¶À¯´ë
  • spinal leptomeningitis
    ô¼ö¿¬¼ö¸·¿°
  • spinal meningitis
    ô¼ö¸·¿°
  • spinal meningocele
    ô¼ö¸·Å»Ãâ(Áõ), ô¼ö¸··ù
  • spinal muscular atrophy
    ô¼ö±Ù(À°)À§ÃàÁõ
  • spinal mydriasis
    ô¼öµ¿°øÈ®´ë
  • spinal nerve
    ô¼ö½Å°æ
  • spinal nerve root
    ô¼ö½Å°æ»Ñ¸®, ô¼ö½Å°æ±Ù
  • spinal reflex
    ô¼ö¹Ý»ç
  • spinal root
    ô¼ö½Å°æ»Ñ¸®, ô¼ö½Å°æ±Ù
  • spinal segment
    ô¼öºÐÀý
  • spinal shock
    ô¼ö¼îÅ©
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • spinal mydriasis
    ô¼öµ¿°øÈ®´ë
  • spinal nerve
    ô¼ö½Å°æ
  • spinal accessory nerve
    ô¼ö´õºÎ½Å°æ
  • spinal trigeminal nucleus
    ô¼ö»ïÂ÷½Å°æÇÙ
  • spinal vestibular nucleus
    ô¼ö¾È¶ãÇÙ
  • posterior spinal sclerosis
    µÚô¼ö°æÈ­Áõ
  • progressive spastic spinal paralysis
    ÁøÇà°æÁ÷ô¼ö¸¶ºñ
  • spasmodic spinal paralysis
    (¢¡spastic spinal paralysis) °æÁ÷ô¼ö¸¶ºñ
  • spastic spinal paralysis
    °æÁ÷ô¼ö¸¶ºñ
  • spinal evoked potential
    ô¼öÀ¯¹ßÀüÀ§
  • spinal radiculitis
    ô¼ö»Ñ¸®¿°
  • spinal reflex
    ô¼ö¹Ý»ç
  • spinal root
    ô¼ö»Ñ¸®
  • spinal nerve root
    ô¼ö½Å°æ»Ñ¸®
  • spinal
    ô¼ö-, ôÃß-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • posterior spinal artery ³ª arteria spinalis p.
    µÚô¼öµ¿¸Æ, ÈÄô¼öµ¿¸Æ(ý­ô±âÐÔÑØæ).
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ (¡­Ìãûùñø).
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ(ý­ô±âÐÌãûùñø)
  • posterior spinal veins
    µÚô¼öÁ¤¸Æ
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõܨ àõ).
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõ ܨàõ)
  • primordium of spinal extensor muscles
    ôÁÖÆï±Ù¿ø±â
  • progressive spastic spinal paralysis
    ÁøÇ༺ °æ¼º ô¼ö¸¶ºñ(òäú¼àõÌâàõô±âÐ Ýö).
  • progressive spastic spinal paralysis
    ÁøÇ༺ °æ¼º ô¼ö¸¶ºñ(òäú¼àõ Ìâàõ ô±âÐØ¦Ýö)
  • progressive spinal amyotrophy
    ÁøÇ༺ ô¼ö¼º ±ÙÀ§ÃàÁõ(òäú¼àõô±âÐàõÐÉê×õê ñø).
  • progressive spinal amyotrophy
    ÁøÇ༺ ô¼ö¼º ±ÙÀ§ÃàÁõ(òäú¼àõ ô±âÐàõ ÐÉê×õêñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • olfactory disorders
    Èİ¢Àå¾Ö
  • organic voice disorders
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • platelet function disorders
    Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
  • postpartum disorders
    »êÈÄ Àå¾Ö(º´)
  • psychogenic voice disorders
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • sensation disorders
    Áö°¢<°¨°¢>Àå¾Ö .
  • sex limited disorders
    ÇѼºÀå¾Ö(ùÚàõî¡äô)
  • sex linked disorders
    ¹Ý¼ºÀå¾Ö(Úáàõî¡äô)
  • sexual and gender identity disorders
    ¼º ¹× Á¤½Å¼ºÀû ÁÖü¼ºÀå¾Ö(º´)
  • sleep-related disorders
    ¼ö¸é°ü·ÃÀå¾Ö(º´)
  • social stress, mood disorders and
    »çȸÀû ½ºÆ®·¹½º
  • somatic disorders
    ½ÅüÀå¾Ö(ãóô÷î¡äô).
  • specific developmental disorders of scholastic skill
    ƯÁ¤ Çо÷±â¼ú ¹ß´ÞÀå¾Ö
  • specific developmental disorders of speech and languages
    ƯÁ¤ ¸»Çϱâ¿Í ¾ð¾îÀÇ ¹ß´ÞÀå¾Ö
  • steroid-induced disorders
    ½ºÅ×·ÎÀ̵å À¯¹ßÀå¾Ö(º´).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Sections of spinal cord
    ô¼öÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ô¼öÀÇ ´Ü¸é
  • Spinal veins
    ô¼öÁ¤¸Æ
    [¿¾ ¿ë¾î] ô¼öÁ¤¸Æ
  • Primordium of spinal extensor muscles
    ôÁÖÆï±Ù¿ø±â
    [¿¾ ¿ë¾î] ôÃ߽űٿø±â
  • Spinal myotome
    ôÃß±ÙÀ°ºÐÀý
    [¿¾ ¿ë¾î] ôÃß±ÙÀý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
jour journal
NEJM New England Journal of Medicine
ASDC Association of Sleep Disorders Centers; ¹Ì±¹ ¼ö¸é Áúȯ ¼¾ÅÍ Çùȸ
DIMS Disorders of Initiating & Maintaining Sleep; ÀÔ¸éÀå¾Ö ¹× ¼ö¸é À¯Áö Àå¾Ö; ºÒ¸éÁõ
DOES Disorders of Excessive Somnolence; °ú´Ù ¼ö¸é Àå¾Ö
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EDI Eating Disorders Inventory
ICSD International Classification of Sleep Disorders
IDD Iodine Deficiency Disorders
LBD Low-back disorders
NINDS National Institute of Neurological Disorders and Stroke
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • spinal musc of neck
    ¸ñ °¡½Ã±Ù, °æ±Ø±Ù
  • spinal muscle of head
    ¸Ó¸® °¡½Ã±Ù, µÎ±Ø±Ù
  • spinal nerve
    ô¼ö ½Å°æ
    ô¼ö¿Í º¹ºÎ, ÈäºÎ, »çÁö°£¿¡ ÀÓÆÞ½º¸¦ Àü´ÞÇÏ´Â ¸»ÃÊ ½Å°æ.
  • spinal nociceptive projection cell
    ô¼ö À¯ÇØ Åõ»ç ¼¼Æ÷
  • spinal nociceptive transmission
    ô¼ö À¯ÇØ Àü´Þ
  • spinal pain transmission
    ô¼ö µ¿Åë Àü´Þ
  • spinal pain transmission neuron
    ô¼ö µ¿Åë Àü´Þ ´º¿ì·±
  • spinal pathway
    ô¼ö °æ·Î
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • spinal reflex
    ô¼ö ¹Ý»ç
    ³ú¿Í ô¼ö »çÀ̸¦ Àý´ÜÇÑ ½ÇÇè µ¿¹°À» ô¼ö µ¿¹°À̶ó°í Çϸç, ÀÌ Ã´¼ö µ¿¹°¿¡¼­ º¼ ¼ö ÀÖ´Â ¹Ý»ç ±â´ÉÀ» ô¼ö ¹Ý»ç¶ó°í ÇÑ´Ù. ¿¹¸¦ µé¸é, ¿¡¼­ ³ú¿Í ô¼ö »çÀ̸¦ Àý´ÜÇÑ Ã´¼ö °³±¸¸®¿¡ ÃÊ»êÀ» ¹Ù¸¥ Á¾À̸¦ ´Ù¸®¿¡ ºÙÀ̸é ÀÚ±ØÀ» ¹Þ¾Æ ´Ù¸®¸¦ ¿òÃ÷¸°´Ù. ¿îµ¿°èÀÇ ¹Ý»ç·Î¼­´Â »çÁöÀÇ ±ÙÀ» ½ÅÀå½ÃŰ¸é ±× ±ÙÀÌ ¼öÃàÇÏ´Â ½ÅÀå ¹Ý»ç¿Í ÇǺθ¦ ÀÚ±ØÇßÀ» ¶§ »çÁö°¡ ¸öÅë ÂÊÀ¸·Î ±Á¾îÁö´Â ±¼±Ù ¹Ý»ç°¡ ÀÖ´Ù. ½ÅÀå ¹Ý»çÀÇ ¼ö¿ë±â´Â ±Ù ¼Ó¿¡ ÀÖ´Â ±Ù¹æÃßÀε¥, À̰ÍÀÌ ½ÅÀåµÇ¸é ±¸½É¼º Ãæ°ÝÀ» ÀÏÀ¸ÄÑ Ã´¼ö ÁßÃß¿¡¼­ ÀüȯµÇ¾î ¿îµ¿ ½Å°æ¿¡ Àü´ÞµÇ°í, °á±¹ ½ÅÀåµÇ¾ú´ø ±ÙÀÌ ¼öÃàÇÏ´Â ¹Ý»çÀÌ´Ù. ±ÙÀÌ ½ÅÀåµÇ¾î ±æ°Ô ´Ã¾î³ª¸é ¼öÃàÇÏ¿© ±× ±æÀ̸¦ ¿ø·¡´ë·Î µÇµ¹¸®´Â ÀÛ¿ëÀ» ÇÏ´Â °ÍÀ¸·Î¼­, ±ÙÀÇ ±æÀ̸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ´Â ¹Ý»ç¶ó°íµµ ÇÒ ¼ö ÀÖ´Ù. °üÀý Çϳª¿¡´Â ½Å±Ù°ú ±¼±ÙÀÌ Àִµ¥ µÑ ´Ù ½ÅÀå ¹Ý»ç°¡ ÀÖ¾î ±ÙÀÇ ±æÀ̸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇϱ⠶§¹®¿¡ °üÀýÀÌ °íÁ¤µÇ´Â °ÍÀÌ´Ù. ¹°·Ð ô¼ö µ¿¹°¿¡¼­´Â ¾ÆÁ÷ ½Å±Ù°ú ±¼±Ù°úÀÇ ½ÅÀå ¹Ý»ç¸¦ ÅëÇÕÇÒ ¼ö°¡ ¾øÀ¸¹Ç·Î ³ú°£ÀÇ ÅëÇÕ¿¡ ÀÇÇØ¼­¸¸ ºñ·Î¼Ò °üÀýÀÌ °íÁ¤µÇ°í ÀÚ¼¼¸¦ À¯ÁöÇÒ ¼ö ÀÖ°Ô µÈ´Ù. ±¼°î ¹Ý»ç´Â ÇǺηκÎÅÍÀÇ ±¸½É¼º Ãæ°ÝÀÌ Ã´¼öÀÇ ¹Ý»ç ÁßÃß¿¡¼­ »çÁöÀÇ ±¼±Ù¿¡ ÀÖ´Â ¿îµ¿ ½Å°æÀ¸·Î Àü´ÞµÇ´Â ¹Ý»çÀÌ´Ù. ¶ß°Å¿î °Í¿¡ ¼ÕÀÌ ´êÀ¸¸é ¹Ý»çÀûÀ¸·Î ±× ¼ÕÀ» ¿À¹Ç¸®´Â ÀÛ¿ëÀ» ÇÑ´Ù. ô¼ö¿¡´Â ÀÌ ¹Û¿¡µµ ÀÚÀ²½Å°æ ¹Ý»ç ÁßÃß°¡ ÀÖ´Ù. ¿¹ÄÁ´ë ¹è´¢ ÁßÃß, ¹èº¯ ÁßÃß¿Í ±× ¹Û¿¡ ºÒ¿ÏÀüÇÑ lÂ÷ ÁßÃ߷μ­ ¹ßÇÑ, Á¥ ºÐºñ, ½ÉÀå ¹Úµ¿ ÃËÁø, Ç÷°ü ¼öÃà µîÀ» ÀÏÀ¸Å²´Ù
  • spinal segment
    ô¼ö ºÐÀý
    1. ô¼ö´Â °¢ À§Ä¡¿¡ µû¶ó Å©±â¿Í ÇüÅÂ, ȸ¹éÁú°ú ¹éÁúÀÇ »ó´ëÀûÀÎ ¾ç, ±×¸®°í ȸ¹éÁúÀÇ ¹è¿­ÀÌ ´Ù¾çÇÏ°Ô ³ªÅ¸³­´Ù. 2. °æºÎÂÊÀ¸·Î ¿Ã¶ó°¥¼ö·Ï ¸ð¾çÀº ±¸Çü¿¡¼­ Ÿ¿øÇüÀ¸·Î º¯Çϰí, ȸ¹éÁúÀÇ »ó´ëÀûÀÎ ¾çµµ ÁÙ¾îµé¾î ¹éÁúÀÇ ¾çÀÌ »ó´ëÀûÀ¸·Î ¸¹¾ÆÁø´Ù.
  • spinal tap
    ô¼ö õÀÚ
  • spinal thalamic pathway
    ô¼ö ½Ã»ó·Î
  • spinal trigeminal nucleus
    »ïÂ÷ ½Å°æ ô¼ö ÇÙ, »ïÂ÷ ½Å°æ ô¼ö °¨°¢ ÇÙ
    ³ú±³, ¿¬¼ö ¹×, °æÃß C1, C2, C3¿¡ ÀÖÀ¸¸ç,
  • spinal veins
    ô¼ö Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
phobic disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable.
(12 Dec 1998)
civil disorders Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change.
(12 Dec 1998)
phosphorus metabolism disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
photosensitivity disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
(12 Dec 1998)
mood disorders Those disorders that have a disturbance in mood as their predominant feature.
(12 Dec 1998)
combat disorders Neurotic reactions to unusual, severe, or overwhelming military stress.
(12 Dec 1998)
communication disorders Disorders characterised by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing.
(12 Dec 1998)
motor skills disorders Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living.
(12 Dec 1998)
platelet function disorders <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(31 Dec 1997)
multifactorial or multigenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
consciousness disorders Organic mental disorders in which there is marked impairment of awareness.
(12 Dec 1998)
polygenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
myeloproliferative disorders A group of disease states which primarily involve the bone marrow and the production blood cells.
Examples include polycythaemia vera, leukaemia, myelofibrosis and primary thrombocytopenia.
(27 Sep 1997)
craniomandibular disorders Diseases or disorders of the muscles of the head and neck, with special reference to the masticatory muscles. The most notable examples are temporomandibular joint disorders and temporomandibular joint dysfunction syndrome.
(12 Dec 1998)
cumulative trauma disorders Harmful and painful condition caused by overuse or overexertion of some part of the musculoskeletal system, often resulting from work-related physical activities. It is characterised by inflammation, pain, or dysfunction of the involved joints, bones, ligaments, and nerves.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á